Patent · US Active

Methods for treatment of cancer

US8916381B1 · kind B1 · utility

178Cited by
26References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2014
Grant dateDec 23, 2014
Priority date
Expiry dateAug 22, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/15071
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.